[HTML][HTML] Restenosis after coronary and peripheral intervention: efficacy and clinical impact of cilostazol

G de Donato, F Setacci, M Mele, G Giannace… - Annals of vascular …, 2017 - Elsevier
Restenosis is one of the main complications in patients undergoing coronary or peripheral
revascularization procedures and is the leading cause for their long-term failures. Cilostazol …

Loading doses of ticagrelor versus clopidogrel in preventing periprocedural myocardial infarction in Asian patients with acute coronary syndrome

YR Zhang, ZK Xue, KY Chen, LX Xu, WD Wang… - …, 2021 - journals.sagepub.com
Background: Periprocedural myocardial infarction is a common complication following
percutaneous coronary intervention. The present study was conducted with an aim to …

Triple Antiplatelet Therapy and Combinations with Oral Anticoagulants after Percutaneous Coronary Intervention

B Rowland, JA Batty, R Mehran… - … Principles and Practice, 2022 - Wiley Online Library
Dual anti‐platelet therapy (DAPT), comprising aspirin and a P2Y 12 receptor antagonist, is
recommended following stent implantation during percutaneous coronary intervention (PCI) …

Post PCI myocardial infarction A Silent Killer Fact or fiction. Does it really exist? Where do we stand?

NU Khan, T Saghir, MS Talpur, MT Farman… - Pakistan Heart …, 2020 - pkheartjournal.com
Objective: To determine the frequency of peri-pocedural myocardial infarction in patients
with stable coronary artery disease undergoing elective percutaneous coronary angioplasty …

[PDF][PDF] TITLE PAGE RESTENOSIS AFTER CORONARY AND PERIPHERAL INTERVENTION: 2 EFFICACY AND CLINICAL IMPACT OF CILOSTAZOL 3

G de Donato, F Setacci, MA Mele, G Giannace - 2017 - cyberleninka.org
ABSTRACT 1 Restenosis is one of the main complications in patients undergoing coronary
or peripheral 2 revascularization procedures and is the leading cause for their long-term …